MedPath
Found 7 clinical trials|View Analysis
Sort by:

Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC.

Phase 2
Recruiting
Conditions
Pancreatic Cancer
Surgery
Interventions
Drug: Placebo
Drug: Propranolol
First Posted Date
2023-11-22
Last Posted Date
2024-03-28
Lead Sponsor
Zealand University Hospital
Target Recruit Count
30
Registration Number
NCT06145074
Locations
🇩🇰

Department of Surgical Gastroenterology, København, Denmark

🇩🇰

Ismail Gögenur, Køge, Denmark

Accuracy of Real Time Characterization in Artificial Intelligence-assisted Colonoscopy

Not Applicable
Active, not recruiting
Conditions
Colorectal Neoplasms
Colorectal Cancer
Colorectal Adenoma
Interventions
Device: AI-assisted colonoscopy
First Posted Date
2023-03-03
Last Posted Date
2024-02-13
Lead Sponsor
Ismail Gögenur
Target Recruit Count
395
Registration Number
NCT05754229
Locations
🇩🇰

Holbæk Hospital, Holbæk, Denmark

🇩🇰

Næstved Hospital, Næstved, Denmark

🇩🇰

Zealand University Hospital, Køge, Denmark

and more 1 locations

Gene and Protein Expression Profiles After Treatment of Actinic Keratoses

Phase 2
Recruiting
Conditions
Actinic Keratoses
Interventions
First Posted Date
2023-02-23
Last Posted Date
2023-02-23
Lead Sponsor
Ismail Gögenur
Target Recruit Count
48
Registration Number
NCT05740969
Locations
🇩🇰

Zealand University Hospital, Roskilde, Region Sjælland, Denmark

Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy

Not Applicable
Active, not recruiting
Conditions
Colorectal Neoplasms
Colorectal Adenoma
Colorectal Cancer
Interventions
Device: AI-assisted colonoscopy
First Posted Date
2023-02-22
Last Posted Date
2024-02-13
Lead Sponsor
Ismail Gögenur
Target Recruit Count
800
Registration Number
NCT05740137
Locations
🇩🇰

Holbæk Hospital, Holbæk, Denmark

🇩🇰

Zealand University Hospital, Køge, Denmark

🇩🇰

Næstved Hospital, Næstved, Denmark

and more 1 locations

Electroporation and Immunotherapy in Metastatic Colorectal Cancer

Phase 2
Terminated
Conditions
Metastatic Colorectal Cancer
Interventions
Device: Irreversible electroporation
Device: Calcium electroporation
Drug: Pembrolizumab
First Posted Date
2022-11-08
Last Posted Date
2024-06-03
Lead Sponsor
Ismail Gögenur
Target Recruit Count
4
Registration Number
NCT05609656
Locations
🇩🇰

Zealand University Hospital, Køge, Denmark

Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer

Phase 2
Terminated
Conditions
Pancreas Cancer
Interventions
Drug: Nivolumab
Device: Irreversible electroporation (IRE)
First Posted Date
2022-06-28
Last Posted Date
2023-09-15
Lead Sponsor
Ismail Gögenur
Target Recruit Count
9
Registration Number
NCT05435053
Locations
🇩🇰

Zealand University Hospital, Roskilde, Denmark

The Effect of Melatonin in Patients With Low Anterior Resection Syndrome

Phase 2
Active, not recruiting
Conditions
Low Anterior Resection Syndrome
Interventions
Drug: Melatonin
Drug: Placebo
First Posted Date
2021-09-13
Last Posted Date
2023-04-25
Lead Sponsor
Ismail Gögenur
Target Recruit Count
21
Registration Number
NCT05042700
Locations
🇩🇰

Zealand University Hospital, Køge, Region Sjælland, Denmark

© Copyright 2025. All Rights Reserved by MedPath